GENEVA, Oct. 15 -- SUNRISE ONCOLOGY (HONG KONG) LIMITED filed a patent application (IB2025/058838) for “MACROCYCLIC COMPOUNDS AS RAS INHIBITORS FOR THE TREATMENT OF CANCER”. With publication no. WO/2026/047641, here are the other details related to the patent application:
Kind: Correction of entry in Section I of the PCT Gazette [A8]
IPC: A61P 35/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....